James E Fickenscher - Net Worth and Insider Trading
James E Fickenscher Net Worth
The estimated net worth of James E Fickenscher is at least $2 Million dollars as of 2024-12-27. James E Fickenscher is the Senior Vice President & CFO of Antares Pharma Inc and owns about 270,216 shares of Antares Pharma Inc (ATRS) stock worth over $2 Million. James E Fickenscher is also the CFO of Zynerba Pharmaceuticals Inc and owns about 378,087 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $491,513. Details can be seen in James E Fickenscher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James E Fickenscher has not made any transactions after 2023-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James E Fickenscher
James E Fickenscher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E Fickenscher owns 2 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , and Antares Pharma Inc (ATRS) .
Click here to see the complete history of James E Fickenscher’s form 4 insider trades.
Insider Ownership Summary of James E Fickenscher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | Chief Financial Officer |
| ATRS | Antares Pharma Inc | 2016-03-18 | Senior Vice President & CFO |
James E Fickenscher Latest Holdings Summary
James E Fickenscher currently owns a total of 2 stocks. Among these stocks, James E Fickenscher owns 270,216 shares of Antares Pharma Inc (ATRS) as of March 18, 2016, with a value of $2 Million and a weighting of 75.45%. James E Fickenscher also owns 378,087 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of September 13, 2023, with a value of $491,513 and a weighting of 24.55%.
Latest Holdings of James E Fickenscher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRS | Antares Pharma Inc | 2016-03-18 | 270,216 | 5.59 | 1,510,507 |
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | 378,087 | 1.30 | 491,513 |
Holding Weightings of James E Fickenscher
James E Fickenscher Form 4 Trading Tracker
According to the SEC Form 4 filings, James E Fickenscher has made a total of 0 transactions in Antares Pharma Inc (ATRS) over the past 5 years. The most-recent trade in Antares Pharma Inc is the acquisition of 135,000 shares on March 18, 2016, which cost James E Fickenscher around $97,200.
According to the SEC Form 4 filings, James E Fickenscher has made a total of 3 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 8,998 shares on September 13, 2023, which brought James E Fickenscher around $11,967.
Insider Trading History of James E Fickenscher
- 1
James E Fickenscher Trading Performance
GuruFocus tracks the stock performance after each of James E Fickenscher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Fickenscher is 1.83%. GuruFocus also compares James E Fickenscher's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Fickenscher within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James E Fickenscher's insider trading performs compared to the benchmark.
Performance of James E Fickenscher
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.25 | | | | | |
| Relative Return to S&P 500(%) | 11.66 | | | | | |
James E Fickenscher Ownership Network
James E Fickenscher Owned Company Details
What does Zynerba Pharmaceuticals Inc do?
Who are the key executives at Zynerba Pharmaceuticals Inc?
James E Fickenscher is the Chief Financial Officer of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include director & Chairman & Chief Exec. Officer Armando Anido , President Terri B Sebree , and VP & Commercial & Business Dev. Brian Rosenberger .
Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary
Over the past 18 months, James E Fickenscher made 1 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 8,998. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 17,830 shares made by Armando Anido , a net sale of 12,401 shares made by Terri B Sebree , and a net sale of 6,411 shares made by Brian Rosenberger .
In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,145 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,145 shares.
Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zynerba Pharmaceuticals Inc Insider Transactions
James E Fickenscher Mailing Address
Above is the net worth, insider trading, and ownership report for James E Fickenscher. You might contact James E Fickenscher via mailing address: C/o Auxilium Pharmaceuticals, Inc., 640 Lee Road, Chesterbrook Pa 19087.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
